Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price ▲ | Potential |
|---|---|---|---|---|---|---|---|
| Immunogen Inc. | 7 | 0 | 1 | 0 | €28.97 | - | - |
| Natural Alternat. | 17 | 1 | 0 | 0 | €5.70 | - | - |
| Vericel Corp. | 1 | 0 | 0 | 0 | €43.00 | - | - |
| Aldeyra Therapeutics Inc. | 2 | 0 | 0 | 0 | €3.96 | - | - |
| Brainstorm Cell | 1 | 0 | 0 | 0 | €0.38 | - | - |
| Lemaitre Vascular Inc | 1 | 0 | 0 | 0 | €61.00 | - | - |
| Blueprint Medicines Corp | 1 | 0 | 1 | 0 | €101.95 | - | - |
| Pro-Dex Inc. | 15 | 0 | 0 | 0 | €16.60 | - | - |
| Lightpath Techs A | 3 | 0 | 0 | 0 | €1.30 | €2.78 | 114.123% |
| Cerus Corp. | 3 | 0 | 1 | 0 | €1.58 | €2.80 | 77.135% |
| SCYNEXIS Inc. | 5 | 0 | 1 | 0 | €1.58 | €3.00 | 89.514% |
| Akebia Therapeutics Inc. | 8 | 3 | 1 | 0 | €1.18 | €3.60 | 205.526% |
| Nektar Therapeutics | 3 | 1 | 1 | 0 | €1.55 | €3.70 | 138.402% |
| Cutera Inc. | 1 | 0 | 0 | 0 | €2.26 | €3.75 | 65.636% |
| Xeris Biopharma Holdings Inc. | 4 | 0 | 0 | 0 | €1.64 | €4.39 | 168.253% |
| Heron Therapeutics Inc. | 9 | 1 | 3 | 0 | €2.22 | €4.57 | 106.399% |
| Geron Corp. | 11 | 0 | 3 | 0 | €3.67 | €4.60 | 25.423% |
| Cara Therapeutics Inc. | 8 | 1 | 1 | 0 | €0.72 | €4.63 | 545.649% |
| Adverum Biotechnologies Inc. | 6 | 1 | 2 | 0 | €1.38 | €4.66 | 237.768% |
| Vanda Pharmaceuticals | 4 | 0 | 1 | 0 | €4.38 | €5.00 | 14.155% |
| Chromadex Corp | 10 | 2 | 1 | 0 | €3.38 | €5.76 | 70.308% |
| Glycomimetics Inc. | 5 | 0 | 0 | 0 | €1.53 | €7.35 | 379.869% |
| Fate Therapeutics Inc. | 5 | 2 | 2 | 1 | €3.72 | €8.27 | 122.449% |
| Codexis Inc. | 4 | 2 | 0 | 0 | €2.97 | €8.35 | 181.182% |
| Esperion Therapeutis.Inc. | 13 | 0 | 2 | 0 | €1.93 | €8.39 | 333.844% |